← Back to headlines
Eli Lilly Sues Companies Over Illegal Sales of Experimental Weight-Loss Drug
Eli Lilly has filed six lawsuits against pharmacies and peptide vendors for the alleged illegal sale of its experimental weight-loss drug, retatrutide, aiming to crack down on the illicit market.
12 Aug, 09:41 — 12 Aug, 13:07
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (51/100)4 sources30/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left2
Left (2)
cnbcYahoo
Center1
Center (1)
marketwatch
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US4
ℹAll sources from US region
Sources
Showing 3 of 4 sources
cnbcMostly Factual22h ago
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.
Read full article →marketwatchMostly Factual19h ago
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.
By Jaimy Lee
Read full article →seeking-alphaMixed23h ago
Lilly files six lawsuits to crack down on black market retatrutide weight-loss shots
Read full article →Coverage Timeline
First report: seeking-alpha · 12 Aug, 09:41|Full coverage: 4 · 3h|Window: 3h
Left-leaningCenterRight-leaning
